PubMed Health⌕ Search

Biomedical subjects

Juliette Cubanski

Publications and source records attributed to Juliette Cubanski.

11 recordsLinked to original sources
PubMed2006

Status report on Medicare Part D enrollment in 2006: analysis of plan-specific market share and coverage.

The centerpiece of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 was the Part D drug benefit, provided through new stand-alone prescription drug plans (PDPs) and Medicare Advantage prescription drug (MA-PD) plans. We examine 2006 Part D enrollment data to analyze organization- and plan-level market share and enrollment by plan type, benefit design, and gap coverage. Ten organizations captured 72 percent of Part D enrollment, primarily in low-premium plans and those with name recognition. More than twelve million Part D enrollees without low-income subsidies enrolled in plans with limited or no gap coverage in 2006, but the number with actual spending in the gap remains to be seen.

Aged↗
PubMed2005

Options for federal coverage of the uninsured in 2005.

Current approaches to reducing the number of uninsured include insurance tax credits for individuals and employers, expanding private group coverage, expanding eligibility for public programs, creating new public programs, and reforming insurance markets. Proposals vary in how they would expand coverage, how many uninsured would be covered, and how much they would cost. Although the costs of expanding coverage are significant, so are the costs of high uninsured rates. Moreover, expanding coverage would likely lead to substantial gains in health and productivity.

Federal Government↗
PubMedDate not supplied

Savings from drug discount cards: relief for Medicare beneficiaries?

Beginning in mid-2004, Medicare beneficiaries can enroll in prescription drug discount card programs approved by the federal government. We estimate modest savings for beneficiaries without drug coverage from existing drug discount card programs, with average savings of 17.4 percent over current retail prices. Although estimated percentage savings are greater on generics than brand-name drugs, estimated absolute dollar savings are greater for brands. Medicare-approved discount card savings for individual beneficiaries will depend on current out-of-pocket drug spending, the number and types of drugs used, and specific card program features. Aggregate savings estimates vary widely, based on uncertainty in discounts and program participation rates.

Adolescent↗